Paired ducts in the human male through which semen is ejaculated into the urethra.
Blood in the SEMEN, usually due to INFLAMMATION of the PROSTATE, the SEMINAL VESICLES, or both.
Pathological processes involving the male reproductive tract (GENITALIA, MALE).
A saclike, glandular diverticulum on each ductus deferens in male vertebrates. It is united with the excretory duct and serves for temporary storage of semen. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
A group of TETRAHYDRONAPHTHALENES containing a keto oxygen.
Holmium. An element of the rare earth family of metals. It has the atomic symbol Ho, atomic number 67, and atomic weight 164.93.
Agents affecting the function of, or mimicking the actions of, the autonomic nervous system and thereby having an effect on such processes as respiration, circulation, digestion, body temperature regulation, certain endocrine gland secretions, etc.
The emission of SEMEN to the exterior, resulting from the contraction of muscles surrounding the male internal urogenital ducts.
The male reproductive organs. They are divided into the external organs (PENIS; SCROTUM;and URETHRA) and the internal organs (TESTIS; EPIDIDYMIS; VAS DEFERENS; SEMINAL VESICLES; EJACULATORY DUCTS; PROSTATE; and BULBOURETHRAL GLANDS).
The inability of the male to effect FERTILIZATION of an OVUM after a specified period of unprotected intercourse. Male sterility is permanent infertility.
The emission of SEMEN and seminal fluid during the act of preparation for sexual intercourse, i.e. before there is penetration, or shortly after penetration.
The condition of an anatomical structure's being constricted beyond normal dimensions.
Physiological disturbances in normal sexual performance in either the male or the female.

Surgical therapy in infertile men with ejaculatory duct obstruction: technique and outcome of a standardized surgical approach. (1/51)

In severe oligozoospermia or azoospermia, low ejaculate volume, low ejaculate pH and little or no fructose in seminal plasma suggest an obstruction of the seminal pathways at the level of the prostate gland, when vasal aplasia and ejaculatory disorders are excluded. We report on our standardized surgical approach in 16 consecutive patients with this condition after clinical evaluation, semen analysis, endocrine assessment, testicular biopsy and transrectal ultrasonography. Pre-operatively, sperm analysis demonstrated typical low-volume ejaculates with azoospermia in 12 and severe oligozoospermia in four cases. Ultrasonography demonstrated seven central (Mullerian) and five lateral cystic lesions. Four cases with central obstruction revealed no ultrasonographic pathology. After intra-operative vasopuncture and vasography for definite localization of the level of obstruction, transurethral incision and/or resection of ejaculatory ducts (TURED) was performed. Patency was proven in 15 out of 16 cases by 'intra-operative chromotubation'. In nine out of 12 patients, spermatozoa could be harvested intra-operatively from the vas. During the follow-up of 12 months, post-operative ejaculates showed persistent patency in six out of seven Mullerian cysts with concomitant improvement of sperm quality. Only three of the other nine cases remained patent with the worst results in lateral cystic lesions. Only two of the patients with Mullerian cysts have fathered a child so far. The data provide evidence for the effectiveness of surgical treatment of ejaculatory duct obstruction, especially in the case of central cystic lesions. The combination of surgery, cryostoring of spermatozoa retrieved intra-operatively and the possible storage of ejaculated spermatozoa post-operatively creates the possibility of subsequently using reproductive techniques if pregnancy is not achieved.  (+info)

Oestrogen in fluid transport in efferent ducts of the male reproductive tract. (2/51)

This review focuses on the importance of oestrogen and oestrogen receptors in the male reproductive system, with a special interest in the newly discovered role of oestrogen in the regulation of fluid reabsorption in the efferent ductules of the testis. Early work on oestrogen synthesis indicated that Leydig and Sertoli cells were the only important cells in the production of this steroid in the adult testis. However, more recent work has shown that germ cells and spermatozoa also contain aromatase and produce oestrogen. The observation that germ cells synthesize oestrogen contributed to a new hypothesis that oestrogen in the lumen of the male reproductive tract targets the epithelial lining of efferent ductules and the epididymis. The location of nuclear oestrogen receptors in the male reproductive tract has also been investigated and it has been found that oestrogen receptor alpha is more abundant in the efferent ductules of the testis than in any other tissue of the male or female. In all species examined to date, oestrogen receptor alpha has been found to be abundant in the efferent ductules. The structure and function of the efferent ductules are taken into account as these tubules are responsible for the reabsorption of almost 90% of the luminal rete testis fluid. Thus, it was logical to hypothesize that oestrogen receptors play a role in the regulation of fluid reabsorption in efferent ductules. The oestrogen receptor alpha knockout mouse was used to help define this role of the receptor in males. In this animal model, the efferent ductules are altered markedly from a reabsorptive epithelium to a squamous epithelium devoid of lysosomes and endocytotic organelles. Although the separate roles for oestrogens and androgens in the regulation of fluid reabsorption are controversial and remain to be resolved, it is now established that loss of oestrogen receptor function in males interferes with the resorptive function of efferent ductules, a function that is essential for fertility. Future studies will focus on the biochemical and physiological mechanisms involved in the regulation of water and ion movement by oestrogen in the male reproductive tract.  (+info)

Human ejaculatory duct: parameters of smooth muscle motor activity and modulatory role of autonomic drugs. (3/51)

The contractile behaviour and effects of several autonomic drugs on the motor activity of human isolated ejaculatory ducts were investigated. Ejaculatory ducts exhibited spontaneous contractions characterised by an amplitude of 2.35 +/- 0.28 mN, a duration of 62. 9 +/- 3.72 s and a frequency of 0.64 +/- 0.014 waves min-1. Acetylcholine (10-5-10-4 m) induced a slight increase in basal tone and in the frequency of the contraction waves. These effects were suppressed by atropine (10-4 m). Noradrenaline (norepinephrine) increased the basal tone and frequency of spontaneous contractions in a dose-dependent manner. These responses were competitively inhibited by HEAT, a selective a1-adrenoceptor antagonist. These preliminary functional findings, indicating the presence of spontaneous motor activity of human ejaculatory ducts and its possible control by adrenergic agonists, suggests a physiological role for human ejaculatory duct in the propulsion of semen from the seminal vesicle towards the urethra.  (+info)

Estrogen receptor alpha has a functional role in the mouse rete testis and efferent ductules. (4/51)

Previous studies of the estrogen receptor-alpha knockout (alpha ERKO) in the male mouse demonstrate that the rete testis and efferent ductules are targets of estrogen. Because the alpha ERKO mouse lacks a functional estrogen receptor alpha (ER alpha) throughout development, it was not known whether the morphological and physiological abnormalities observed in the alpha ERKO male were due to developmental defects or to dysfunctions concurrent with the lack of ER alpha in the tissue. This study was designed to determine if treatment of normal wild-type (WT) mice with the pure antiestrogen, ICI 182,780, (ICI) could reproduce the morphological characteristics seen in alpha ERKO mice. Thirty-day-old male mice were treated for 35 days with either castor oil or ICI. Age-equivalent alpha ERKO mice were used for comparison. Light microscopic examinations of the reproductive tracts revealed dramatic changes in the efferent ductules of treated mice: a 1.7-fold increase in luminal diameter, a 56% reduction in epithelial cell height, a 60% reduction in brush boarder height of nonciliated cells, and an apparent reduction of the number of observable lysosomes and endocytotic vesicles. Testes of ICI-treated mice showed swollen rete testes area (6.5 times larger than control) and a 65% reduction in rete testis epithelium height. However, there were no significant changes in body and testis weights. These results indicate that ER blockage with ICI in WT mice results in morphological changes of the efferent ductules resembling those seen in alpha ERKO siblings of the same age. Based on this study, we conclude that ER alpha has a functional role in the mouse reproductive tract and the aberrant morphology observed in the efferent ductules of the alpha ERKO mouse is likely the result of a concurrent response to the lack of functional ER alpha, and not solely due to the lack of ER alpha during early developmental times.  (+info)

Effect of vasectomy on P34H messenger ribonucleic acid expression along the human excurrent duct: a reflection on the function of the human epididymis. (5/51)

Sperm surface proteins involved in fertilization can be added or modified during epididymal transit. P34H, a human epididymal-sperm protein, appears on the sperm acrosomal cap in the distal caput-proximal corpus epididymis. In previous studies, it was shown that P34H is present on spermatozoa in men of proven fertility, is absent in 50% of men presenting with idiopathic infertility, and that a high proportion of men with normospermic vasovasectomy produce spermatozoa deficient in this sperm surface protein. P34H mRNA was expressed in the principal cells of the epididymis of normal men, predominantly in the corpus region. Recently, results coming from the assisted reproductive technologies have questioned the importance of the human epididymis in sperm maturation. In order to understand the effect of obstruction on the physiological state of the human epididymis and its function in sperm maturation, we have analyzed the expression of P34H mRNA at the level of the vas deferens and along the epididymis of normal and vasectomized men. In situ hybridization experiments showed that obstruction of the vas deferens alters the pattern of P34H mRNA expression compared with the tract of normal tissues. The P34H transcript was detected in the proximal caput epididymis of vasectomized men at a much higher intensity than that observed in the same region of normal tissues, being restricted to the principal cells of the epididymal epithelium. Compared with the normal duct, the lumen of vasectomized men was distended throughout the duct and the height of the epithelium was maximal in the caput. P34H mRNA was detectable in vas deferens, was not affected by vasectomy, and a 912-base pair P34H transcript was restricted to the epithelial cells of the vas deferens. Thus, using P34H as a marker, these results show that vasectomy alters the pattern of gene expression along the human epididymis, and suggest that the vas deferens can be a major contributor to sperm maturation in certain situations.  (+info)

Dual role of the Pax gene paired in accessory gland development of Drosophila. (6/51)

The Drosophila Pax gene paired encodes a transcription factor that is required for the activation of segment-polarity genes and proper segmentation of the larval cuticle, postembryonic viability and male fertility. We show that paired executes a dual role in the development of male accessory glands, the organ homologous to the human prostate. An early function is necessary to promote cell proliferation, whereas a late function, which regulates the expression of accessory gland products such as the sex peptide and Acp26Aa protein, is essential for maturation and differentiation of accessory glands. The late function exhibits in main and secondary secretory cells of accessory glands dynamic patterns of Paired expression that depend in both cell types on the mating activity of adult males, possibly because Paired expression is regulated by negative feedback. The early Paired function depends on domains or motifs in its C-terminal moiety and the late function on the DNA-binding specificity of its N-terminal paired-domain and/or homeodomain. Both Paired functions are absolutely required for male fertility, and both depend on an enhancer located within 0.8 kb of the downstream region of paired.  (+info)

Ductus ejaculatorius peptide 99B (DUP99B), a novel Drosophila melanogaster sex-peptide pheromone. (7/51)

We have characterized a glycosylated, 31 amino-acid peptide of 4932 Da isolated from Drosophila melanogaster males. The mature peptide contains a sugar moiety of 1184 Da at a NDT consensus glycosylation site and a disulfide bond. It is synthesized in the male ejaculatory duct via a 54 amino-acid precursor containing an N-terminal signal peptide and Arg-Lys at the C-terminus which is cleaved off during maturation. The gene contains an intron of 53 bp and is localized in the cytological region 99B of the D. melanogaster genome. The peptide is therefore named DUP99B (for ductus ejaculatorius peptide, cytological localization 99B). The C-terminal parts of mature DUP99B and D. melanogaster sex-peptide (ACP70A) are highly homologous. Injected into virgin females, DUP99B elicits the same postmating responses as sex-peptide (increased oviposition, reduced receptivity). These effects are also induced by de-glycosylated native peptide or synthetic DUP99B lacking the sugar moiety. Presence of the glycosyl group, however, decreases the amount needed to elicit the postmating responses. Homologies in the coding regions of the two exons of DUP99B and sex-peptide, respectively, suggest that the two genes have evolved by gene duplication. Thus, we consider these two genes to be members of the new sex-peptide gene family.  (+info)

Osteopontin expression and regulation in the testis, efferent ducts, and epididymis of rats during postnatal development through to adulthood. (8/51)

Osteopontin (OPN), a multifunctional phosphoprotein found in both hard and soft tissues, was examined in the male reproductive tract. The expression and regulation of OPN in the rat testis, efferent ducts, and epididymis was examined during postnatal development through to adulthood using immunocytochemistry at the light- and electron-microscopic level. Immunoblot analysis revealed a major 30-kDa band for epididymal tissue and a major 60-kDa band for the testis. In the testis, immunostaining of OPN was noted in early germ cells from spermatogonia to early pachytene spermatocytes, suggesting a role for OPN as an adhesive protein binding these cells to the basement membrane and adjacent Sertoli cells. Nonciliated cells of the efferent ducts expressed OPN, whereas a cell- and region-specific distribution of OPN was observed in the epididymis. Reactivity of OPN in the apical region of the cell corresponded to labeling of microvilli, small endocytic vesicles, and endosomes, where OPN may serve to remove calcium from the epididymal lumen and, thus, prevent mineral accumulation and subsequent decrease in sperm fertility. Regulation and postnatal studies revealed that circulating androgens regulate OPN expression in principal cells of the epididymis only. Taken together, the data reveal cell- and region-specific expression and regulation of OPN in the epididymis.  (+info)

The ejaculatory ducts are a pair of small tubes in the male reproductive system that transport sperm from the vas deferens to the urethra, which runs through the penis and carries both semen and urine. Each duct is formed by the joining of the vas deferens and the seminal vesicle, and they pass through the prostate gland before opening into the urethra. The ejaculatory ducts are important for the proper functioning of the male reproductive system as they allow sperm to mix with other fluids from the seminal vesicles and prostate gland to create semen, which is necessary for fertilization.

Hemospermia is the medical term for the presence of blood in semen. It can be caused by various factors, such as inflammation or infection of the urethra, prostate gland, or seminal vesicles; trauma to the genital area; or more serious conditions like tumors. In many cases, the cause remains unknown and the condition resolves on its own within a few weeks. However, it is recommended to consult a healthcare professional if you experience hemospermia to rule out any underlying medical conditions and receive appropriate treatment.

Genital diseases in males refer to various medical conditions that affect the male reproductive and urinary systems, including the penis, testicles, epididymis, vas deferens, seminal vesicles, prostate, and urethra. These conditions can be infectious, inflammatory, degenerative, or neoplastic (cancerous) in nature. Some common examples of male genital diseases include:

1. Balanitis: Inflammation of the foreskin and glans penis, often caused by infection, irritants, or poor hygiene.
2. Prostatitis: Inflammation of the prostate gland, which can be acute or chronic, bacterial or non-bacterial in origin.
3. Epididymitis: Inflammation of the epididymis, a coiled tube at the back of the testicle that stores and carries sperm. It is often caused by infection.
4. Orchitis: Inflammation of the testicle, usually resulting from infection or autoimmune disorders.
5. Testicular torsion: A surgical emergency characterized by twisting of the spermatic cord, leading to reduced blood flow and potential tissue damage in the testicle.
6. Varicocele: Dilated veins in the scrotum that can cause pain, discomfort, or fertility issues.
7. Peyronie's disease: A connective tissue disorder causing scarring and curvature of the penis during erections.
8. Penile cancer: Malignant growths on the penis, often squamous cell carcinomas, which can spread to other parts of the body if left untreated.
9. Benign prostatic hyperplasia (BPH): Non-cancerous enlargement of the prostate gland that can cause lower urinary tract symptoms such as difficulty initiating or maintaining a steady stream of urine.
10. Sexually transmitted infections (STIs): Infectious diseases, like chlamydia, gonorrhea, syphilis, and human papillomavirus (HPV), that can be transmitted through sexual contact and affect the male genital region.

The seminal vesicles are a pair of glands located in the male reproductive system, posterior to the urinary bladder and superior to the prostate gland. They are approximately 5 cm long and have a convoluted structure with many finger-like projections called infoldings. The primary function of seminal vesicles is to produce and secrete a significant portion of the seminal fluid, which makes up the bulk of semen along with spermatozoa from the testes and fluids from the prostate gland and bulbourethral glands.

The secretion of the seminal vesicles is rich in fructose, which serves as an energy source for sperm, as well as various proteins, enzymes, vitamins, and minerals that contribute to maintaining the optimal environment for sperm survival, nourishment, and transport. During sexual arousal and ejaculation, the smooth muscles in the walls of the seminal vesicles contract, forcing the stored secretion into the urethra, where it mixes with other fluids before being expelled from the body as semen.

Tetralones are not a medical term, but rather a chemical classification. They refer to a class of organic compounds that contain a tetralone ring structure, which is a cyclohexanone fused to a benzene ring. These compounds have various applications in the pharmaceutical industry as intermediates in the synthesis of drugs. Some tetralones have been studied for their potential medicinal properties, such as anti-inflammatory and analgesic effects, but they are not themselves approved medical treatments.

Holmium is a chemical element with the symbol Ho and atomic number 67. It's a rare earth metal that belongs to the lanthanide series. In the field of medicine, holmium is used in the form of holmium oxide (HoO) as a component in some medical devices, particularly in laser surgery.

The Holmium:Yttrium-Aluminum-Garnet (Ho:YAG) laser is commonly used in urology for the treatment of kidney stones and various urological conditions. The holmium laser emits light at a wavelength of 2100 nanometers, which is highly absorbed by water and tissue, making it an effective tool for cutting and coagulating tissues with minimal thermal damage to surrounding areas.

It's important to note that direct medical applications of holmium as an element are not common, but rather its use in the form of compounds or medical devices is more prevalent.

I'm sorry for any confusion, but "autonomic agents" is not a medical term or concept that has a specific definition in the field of medicine. The term "autonomic" refers to the part of the nervous system that regulates involuntary physiological functions, such as heart rate, digestion, and respiratory rate. The term "agents," on the other hand, is often used in computer science and artificial intelligence to refer to software entities that can act on behalf of a user or another entity.

Therefore, "autonomic agents" might refer to software programs that are designed to regulate physiological functions autonomously, but this would be more related to the field of biomedical engineering or artificial intelligence than to medicine itself. If you have more context or information about where you encountered this term, I may be able to provide a more specific answer.

Ejaculation is the discharge of semen, typically accompanied by orgasm, during sexual activity. It occurs when the male reproductive system releases semen from the penis. This process is usually brought on by sexual arousal and stimulation, which cause the sperm-carrying vas deferens to contract and push the semen into the urethra, from where it is expelled through the tip of the penis.

There are two types of ejaculation:

1. **Reflex ejaculation**: This occurs when there is a high level of sexual excitement or stimulation, leading to an involuntary and automatic response.
2. **Premature ejaculation**: This refers to the condition where ejaculation happens too quickly, often before or shortly after penetration, causing distress and affecting sexual satisfaction for both partners.

It is essential to understand that a healthy male can experience variations in the timing of ejaculation throughout their life, influenced by factors such as age, stress levels, and overall health. If you have concerns about your ejaculation patterns or any related issues, it is recommended to consult a healthcare professional for advice and treatment options.

"Male genitalia" refers to the reproductive and sexual organs that are typically present in male individuals. These structures include:

1. Testes: A pair of oval-shaped glands located in the scrotum that produce sperm and testosterone.
2. Epididymis: A long, coiled tube that lies on the surface of each testicle where sperm matures and is stored.
3. Vas deferens: A pair of muscular tubes that transport sperm from the epididymis to the urethra.
4. Seminal vesicles: Glands that produce a fluid that mixes with sperm to create semen.
5. Prostate gland: A small gland that surrounds the urethra and produces a fluid that also mixes with sperm to create semen.
6. Bulbourethral glands (Cowper's glands): Two pea-sized glands that produce a lubricating fluid that is released into the urethra during sexual arousal.
7. Urethra: A tube that runs through the penis and carries urine from the bladder out of the body, as well as semen during ejaculation.
8. Penis: The external organ that serves as both a reproductive and excretory organ, expelling both semen and urine.

Male infertility is a condition characterized by the inability to cause pregnancy in a fertile female. It is typically defined as the failure to achieve a pregnancy after 12 months or more of regular unprotected sexual intercourse.

The causes of male infertility can be varied and include issues with sperm production, such as low sperm count or poor sperm quality, problems with sperm delivery, such as obstructions in the reproductive tract, or hormonal imbalances that affect sperm production. Other factors that may contribute to male infertility include genetic disorders, environmental exposures, lifestyle choices, and certain medical conditions or treatments.

It is important to note that male infertility can often be treated or managed with medical interventions, such as medication, surgery, or assisted reproductive technologies (ART). A healthcare provider can help diagnose the underlying cause of male infertility and recommend appropriate treatment options.

Premature ejaculation (PE) is a common sexual disorder characterized by an uncontrolled ejaculation either before or shortly after sexual penetration, with minimal sexual stimulation and before the person wishes it. This can cause distress, frustration, and avoidance of sexual intimacy. The exact cause of PE is not fully understood, but it can be associated with psychological factors like anxiety, depression, relationship issues, as well as biological factors such as abnormal hormone levels, genetics, or nerve damage. Treatment options may include behavioral techniques, medications, and counseling.

Pathological constriction refers to an abnormal narrowing or tightening of a body passage or organ, which can interfere with the normal flow of blood, air, or other substances through the area. This constriction can occur due to various reasons such as inflammation, scarring, or abnormal growths, and can affect different parts of the body, including blood vessels, airways, intestines, and ureters. Pathological constriction can lead to a range of symptoms and complications depending on its location and severity, and may require medical intervention to correct.

Physiological sexual dysfunction refers to any issues or problems that an individual experiences in their sexual response cycle, which can be broken down into four phases: excitement, plateau, orgasm, and resolution. These difficulties may include a lack of desire or interest in sex (low libido), difficulty becoming aroused (erectile dysfunction in men or inadequate lubrication in women), challenges reaching orgasm, or pain during sexual activity (dyspareunia).

Physiological sexual dysfunctions can be caused by a variety of factors, including medical conditions (such as diabetes, heart disease, neurological disorders, or hormonal imbalances), medications (including some antidepressants and blood pressure drugs), substance abuse, surgical procedures, or aging. Psychological factors, such as stress, anxiety, depression, relationship issues, or past traumatic experiences, can also contribute to sexual dysfunction.

It is important to note that sexual dysfunctions are common and nothing to be ashamed of. If you are experiencing symptoms of sexual dysfunction, it is recommended that you consult a healthcare professional for an evaluation and appropriate treatment options.

Ejaculatory duct obstruction is an acquired or congenital pathological condition in which one or both ejaculatory ducts are ... The ejaculatory ducts (ductus ejaculatorii) are paired structures in male reproductive system. Each ejaculatory duct is formed ... Sperm is produced in the testes and enters the ejaculatory ducts via the vas deferens. As it passes by the seminal vesicles, a ... This results in a dry orgasm, where orgasm may still be experienced but without expulsion of semen from the ejaculatory ducts. ...
Surgical therapy in infertile men with ejaculatory duct obstruction: technique and outcome of a standardized surgical approach ... Transurethral resection of the ejaculatory ducts for treating ejaculatory symptoms.. *Ejaculatory duct obstruction in ... Efficacy of transurethral resection of ejaculatory duct for treatment of ejaculatory duct obstruction: report of 60 cases]. ... Surgical therapy for azoospermia with ejaculatory duct obstruction].. *Ejaculatory duct obstruction in the infertile male: ...
The ejaculatory ducts are paired structures in the male reproductive system formed by the union of the vas deferens with the ...
... is a blockage of one or both of the ejaculatory ducts, the tubules which transport a mixture of sperm and seminal vesicle fluid ... What is Ejaculatory Duct Obstruction?. Ejaculatory duct obstruction (or EDO), is a blockage of one or both of the ejaculatory ... What Are The Ejaculatory Ducts?. The ejaculatory ducts are a pair of hollow tubules in the male anatomy that are situated on ... Can Ejaculatory Duct Obstruction Be Prevented?. Currently, there is no known way to prevent ejaculatory duct obstructions. You ...
... It is a thin tube, pair, that penetrates through the posterior surface of the prostate, ... Structurally, the ejaculatory duct, as well as the seminal vesicle, has the same constitution as the vas deferens, presenting ...
Male infertility treatment in India is taken seriously by medical authorities as men are affected by it emotionally as well as physically. By visiting an infertility center in India all facts about male infertility can be known. Treatments for male infertility can be done surgically. Male infertili ...
... deferens and ejaculatory duct to propel them into the urethra and out of the penis during ejaculation. The ejaculatory duct ... Ejaculatory ducts. There are two ejaculatory ducts, left and right side, that are formed by the union of the duct from the ... Middle ejaculatory duct. The middle portion, or the intraprostatic ejaculatory duct, runs 10-15 mm on the posterior surface of ... Proximal ejaculatory duct. Also referred to as the seminal vesicle-ejaculatory duct junction, the proximal portion of the ...
... deferens and ejaculatory duct to propel them into the urethra and out of the penis during ejaculation. The ejaculatory duct ... Ejaculatory ducts. There are two ejaculatory ducts, left and right side, that are formed by the union of the duct from the ... Middle ejaculatory duct. The middle portion, or the intraprostatic ejaculatory duct, runs 10-15 mm on the posterior surface of ... Proximal ejaculatory duct. Also referred to as the seminal vesicle-ejaculatory duct junction, the proximal portion of the ...
... to form a short ejaculatory duct. Each ejaculatory duct passes through the prostate gland and empties into the urethra. ... Ejaculatory Duct. Each ductus deferens, at the ampulla, joins the duct from the adjacent seminal vesicle (one of the accessory ... It receives the ejaculatory duct, which contains sperm and secretions from the seminal vesicles, and numerous ducts from the ... After they leave the testes, the sperm passes through the epididymis, ductus deferens, ejaculatory duct, and urethra. ...
Complete and partial ejaculatory duct obstruction has been implicated as a cause of 1-5% of patients with male infertility. ... Sávio LF, Palmer J, Prakash NS, Clavijo R, Adamu D, Ramasamy R. Transurethral resection of ejaculatory ducts: a step-by-step ... After reaching its ampullary portion behind the bladder, the vas joins with the seminal vesicles, at the ejaculatory duct, ... A prospective comparison of 3 diagnostic methods to evaluate ejaculatory duct obstruction. J Urol. 2004 Jan. 171(1):232-5; ...
... cystic dilation of the ejaculatory duct. The location, shape and volume of the MLC, and the prostate-specific antigen level of ...
Ejaculatory definition: Of or relating to physiological ejaculation. ... Ejaculatory Sentence Examples *. On the other hand, the ejaculatory duct with its verticillate sac in the male of Cypris and ... The ejaculatory duct which opens on the ninth abdominal sternum in the adult male arises in the tenth abdominal embryonic ... Where the vesiculae join the ampullae of the vasa deferentia the ejaculatory ducts are formed; these are narrow and thin-walled ...
During embryonic development, the mesonephric duct forms in males and gives rise to the ejaculatory duct and ductus deferens, ... The sympathetic and parasympathetic ducts are not involved in the development of the ejaculatory duct and ductus deferens. ... Which of the following develops into the ejaculatory duct and ductus deferens? *. A. ... B. Mesonephric duct Explanation. The correct answer is the mesonephric duct. ...
Ejaculatory duct obstruction. *Voiding difficulty (double voiding, hesitancy, decreased stream). *Benign Prostatic Hyperplasia ...
Next, the seminal fluid is propelled forward through the ejaculatory ducts toward the urethra. As it passes the prostate gland ...
From here, the sperm is transported to the ejaculatory duct.. Partially surrounding and separating the epididymis from the ... Last is the tail, which connects to the deferent duct, also referred to as the ductus deferens or vas deferens. ...
Central zone: This surrounds the ejaculatory ducts and makes up around 25% of the prostates total mass. ...
Damage to Ejaculatory Duct?. Other than infection, blood in the ejaculate is the most common problem following a trans-rectal ... Wasnt aware of this before but a quick Google search also revealed that a biopsy can also damage the ejaculatory duct thereby ...
Sperm enter ejaculatory duct • Secretions released • Expulsion • Rhythmical muscle contractions • Expel semen in spurts from ... Female Breast • Each breast contains between 15 and 24 lobules, each with its own mammary duct • Lactation caused by prolactin ...
... ejaculatory duct). Another clear example of mothers curse came from humans in which a male-biased mutation in the mtDNA ...
... that carry a mans sperm from his testicles to his ejaculatory ducts, where the sperm are stored before departure from his body ... Vas Deferens & Ejaculatory Ducts. Toggle Vas Deferens & Ejaculatory Ducts menu options. *Congenital Bilateral Absence of Vas ... that carry a mans sperm from his testicles to his ejaculatory ducts, where the sperm are stored before departure from his body ...
... there are two of these ducts and their purpose is to carry ejaculatory sperm out… ...
Stromal invasion of the IES/ejaculatory duct system and ejaculatory duct intraepithelial invasion by prostate cancer were ... However, the presence/absence of IES/ejaculatory duct system involvement by prostate cancer does not predict seminal vesicle ... ejaculatory duct system to extraprostatic seminal vesicle. We aimed to clarify the manner and clinicopathological significance ... of carcinoma from the muscular wall of seminal vesicles rather than intraepithelial extension from the ejaculatory duct system ...
Central zone − The central zone is part of the prostate gland surrounding the ejaculatory ducts. This zone is nearly 20% of the ... The urinary tract further connects the prostate gland with the ejaculatory ducts. Hence, besides maintaining male reproductive ... The g; and are connected with the prostate canals, and the canals create 12-20 main ducts, which again join with the urethra. ...
Ejaculatory Duct Obstruction - Causes, Symptoms, and Treatment.... September 15, 2023. Common Bladder Disorders - Causes, ...
... a duct that carries spermatozoa from the epididymis to the ejaculatory duct ... noun a duct that carries spermatozoa from the epididymis to the ejaculatory duct ...
The openings to the urethra are called the ejaculatory ducts.. During sexual intercourse, semen is ejaculated out of the ... The organs involved in the male reproductive system include the testes, penis, epididymis, vas deferens, ejaculatory ducts, and ... and ejaculatory dysfunction can prevent a man from depositing sperm within the female reproductive tract. ...

No FAQ available that match "ejaculatory ducts"

No images available that match "ejaculatory ducts"